Familial hypercholesterolaemia

diagnosis of FH as part of a specialist assessment. Commissioners ensure that they commission services that offer DNA testing to people with a clinical diagnosis of FH as part of a specialist assessment. People who are given a clinical diagnosis of FH because they have high cholesterol, family history or other signs are offered DNA testing as part of a specialist assessment. Source guidance Familial hypercholesterolaemia: identification and management. NICE guideline CG71 (2008, updated 2019), recommendation 1.1.6 Definitions of terms used in this quality statement Familial hypercholesterolaemia (FH) FH relates to heterozygous FH only. Clinical diagnosis of FH Assessment for a clinical diagnosis of FH should use all 3 criteria below: • exclusion of secondary causes of hypercholesterolaemia • 2 measurements of LDL-C concentration • assessment against Simon Broome or Dutch Lipid Clinic Network criteria to make a clinical diagnosis of FH in primary care settings. [Adapted from NICE's guideline on familial hypercholesterolaemia, recommendations 1.1.4, 1.1.5 and 1.1.9] DNA testing DNA testing should test for all gene mutations known to cause FH. Methods should meet the standards set out by the UK Genetic Testing Network. Informed consent should be given for DNA testing. Quality statement 4: Diagnosis in children under
